Trials / Completed
CompletedNCT02608970
Safety and Tolerability Study of BMS-986177 in Healthy Subjects
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of BMS-986177 in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 104 (actual)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine the safety, tolerability, and pharmacokinetics of BMS-986177 in healthy subjects
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BMS-986177 | |
| OTHER | Placebo |
Timeline
- Start date
- 2015-12-31
- Primary completion
- 2017-07-23
- Completion
- 2017-07-23
- First posted
- 2015-11-20
- Last updated
- 2017-07-31
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT02608970. Inclusion in this directory is not an endorsement.